drugset / Trial / NCT02822625

Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch

NCT02822625

Phase 3 Completed 69 enrolled Institut de Cancérologie de Lorraine
RandomizedParallel-groupOpen-labelSupportive care

Summary

QUTENZA® is a skin patch with a high concentration of capsaicin (8%) which is the component responsible for spicy peppers. QUTENZA® is indicated for the treatment of peripheral neuropathic pain in non-diabetic adults either alone or in combination with other analgesics. Acute pain experienced during and after the procedure can be relieved by local cooling methods and oral analgesics but the pain remains intense. The hypothesis is that hypnosis via a standardized hypnotic message would increase the local tolerance of the treatment when applying the patch QUTENZA®. To date, there are no studies that can confirm or refute this hypothesis.

Timeline

Start
2016-08-30
Primary completion
2019-07-10
Completion
2019-07-13

Drugs

EvaluationDrugModalityDoseRoute
Background Capsaicin Small molecule 8 % Topical

Indications

No indication recorded.